Загрузка...
Current and future pharmacological therapies for NAFLD/NASH
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and there is no approved pharmacotherapy. The efficacy of vitamin E and pioglitazone has been established in nonalcoholic steatohepatitis (NASH), a progressive form of NAFLD. GLP-1RA and SGLT2 inhibitors, which a...
Сохранить в:
| Опубликовано в: : | J Gastroenterol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Japan
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5847174/ https://ncbi.nlm.nih.gov/pubmed/29247356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-017-1415-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|